Zobrazeno 1 - 10
of 352
pro vyhledávání: '"fibrosis-4 index"'
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 3037-3045 (2024)
Peng Zhou,1 Lingling Ye,2 Shixiao Li3 1Department of Pharmacy, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People’s Republic of China; 2Department of Science and Education, Taizhou Hospital of Zhejiang
Externí odkaz:
https://doaj.org/article/6be10c336c5740be9c4ce42337ed6c49
Autor:
Shinya Yamada, Takashi Kaneshiro, Minoru Nodera, Kazuaki Amami, Takeshi Nehashi, Masayoshi Oikawa, Takayoshi Yamaki, Kazuhiko Nakazato, Takafumi Ishida, Yasuchika Takeishi
Publikováno v:
Journal of Arrhythmia, Vol 40, Iss 3, Pp 585-593 (2024)
Abstract Background The relationship between liver fibrosis and left atrial (LA) remodeling in atrial fibrillation (AF) remains uncertain. We examined the associations between the fibrosis‐4 (FIB4) index, an indicator of liver fibrosis, and both LA
Externí odkaz:
https://doaj.org/article/5a2ecc986a7b41b291f40efbbc86dc86
Publikováno v:
Journal of Inflammation Research, Vol Volume 17, Pp 3967-3982 (2024)
Jia Shi,1,2,* Meng-Jiao Shao,3,* Miao Yu,1,2 Bao-Peng Tang1,2 1Cardiac Pacing and Physiological Department, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, People’s Republic of China; 2Xinjiang Key Laboratory
Externí odkaz:
https://doaj.org/article/6fa31193eefa437c9f5a414605b06dfa
Autor:
Joost Boeckmans, Maurice Michel, Alexander Gieswinkel, Oliver Tüscher, Stavros V. Konstantinides, Jochem König, Thomas Münzel, Karl J. Lackner, Jasmin Ghaemi Kerahrodi, Alexander K. Schuster, Philipp S. Wild, Peter R. Galle, Jörn M. Schattenberg
Publikováno v:
JHEP Reports, Vol 6, Iss 10, Pp 101171- (2024)
Background & Aims: Elevated liver stiffness has been associated with atrial fibrillation (AFib) in the general population. The mechanism underlying this association is unclear. Methods: Participants were recruited from the general population and pros
Externí odkaz:
https://doaj.org/article/dbb6653caaf54e8bbf49c5a6cce8895e
Autor:
Tomoya Iwawaki, Yasuya Inden, Satoshi Yanagisawa, Takayuki Goto, Shun Kondo, Masaya Tachi, Kei Hiramatsu, Ryota Yamauchi, Masafumi Shimojo, Yukiomi Tsuji, Toyoaki Murohara
Publikováno v:
Annals of Noninvasive Electrocardiology, Vol 29, Iss 5, Pp n/a-n/a (2024)
ABSTRACT Background The fibrosis‐5 (FIB‐5) index is a noninvasive marker for assessing the progression of liver fibrosis and predictor in patients with heart failure (HF). This study investigated the association between the FIB‐5 index and resp
Externí odkaz:
https://doaj.org/article/875fd5139dd740f883f72e6927bc07c9
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is a global cause of chronic liver disease. The prevalence of MASLD is high in patients with type 2 diabetes mell
Externí odkaz:
https://doaj.org/article/bb95b6df3f97487f8976fb4fce2f965e
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Our study aimed to conduct a comparative evaluation of various noninvasive tests (NITs) for risk stratification in at-risk population for non-alcoholic fatty liver disease (NAFLD), focusing on cardiovascular and liver-related mortality. A to
Externí odkaz:
https://doaj.org/article/a4dc867cc167465a9ee54c8f59c90f19
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 4, Pp 476-481 (2024)
Background and Aims: We aimed to test the performance of the Fibroscan-aspartate aminotransferase (FAST) score, a noninvasive test, to identify nonalcoholic steatohepatitis (NASH) and significant fibrosis (NASH + ≥F2) in a cohort of patients with a
Externí odkaz:
https://doaj.org/article/0340e47330bc49a595684cece36053a4
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 20, Pp 101-108 (2024)
Jing Xu,* Xiaohao Zhang,* Yan E, Wei Wang, Junshan Zhou, Yanyan Shi, Shuaiyu Chen Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210000, People’s Republic of China*These authors contribute
Externí odkaz:
https://doaj.org/article/ad8b1f73cea34894adf45e54c91a6be3
Autor:
Takeshi Ichikawa, Haruki Oba, Mai Owada, Kazuki Watanabe, Tsubasa Yoshimura, Ayako Fuchigami, Atsushi Nakamura
Publikováno v:
JGH Open, Vol 7, Iss 12, Pp 959-965 (2023)
Abstract Background and Aim In this retrospective study, we evaluated the effects of pemafibrate treatment in patients with metabolic dysfunction‐associated steatotic liver disease (MASLD) and hypertriglyceridemia using non‐invasive stiffness‐b
Externí odkaz:
https://doaj.org/article/a4f20904ea4248a7bccc50065f0e2dea